Blionas A, Giakoumettis D, Klonou A et al (2018) Paediatric gliomas: diagnosis, molecular biology and management. Ann Transl Med 6:251

PubMed  PubMed Central  Article  CAS  Google Scholar 

Immanuel V, Kingsley PA, Negi P et al (2017) Variegated colors of pediatric glioblastoma multiforme: what to expect? Rare Tumors 9:6552

PubMed  PubMed Central  Article  Google Scholar 

Rashed WM, Maher E, Adel M et al (2019) Pediatric diffuse intrinsic pontine glioma: where do we stand? Cancer Metastasis Rev 38:759–770

PubMed  Article  Google Scholar 

Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ansari M, Nasrolahi H, Kani AA et al (2012) Pediatric glioblastoma multiforme: a single-institution experience. Indian J Med Paediatr Oncol 33:155–160

PubMed  PubMed Central  Article  Google Scholar 

Konar SK, Bir SC, Maiti TK et al (2017) A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord. J Neurosurg Pediatr 19:239–248

PubMed  Article  Google Scholar 

Boudaouara O, Charfi S, Bahri M et al (2019) Pediatric high grade gliomas: clinico-pathological profile, therapeutic approaches and factors affecting overall survival. Neurochirurgie 65:63–68

CAS  PubMed  Article  Google Scholar 

Grimm SA, Chamberlain MC (2013) Brainstem glioma: a review. Curr Neurol Neurosci Rep 13:346

PubMed  Article  CAS  Google Scholar 

Felker J, Broniscer A (2020) Improving long-term survival in diffuse intrinsic pontine glioma. Expert Rev Neurother 20:647–658

CAS  PubMed  Article  Google Scholar 

Covarrubias G, Johansen ML, Vincent J et al (2020) PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma. Nanomedicine 28:102216

CAS  PubMed  Article  Google Scholar 

Lieberman NAP, DeGolier K, Kovar HM et al (2019) Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Neuro Oncol 21:83–94

CAS  PubMed  Article  Google Scholar 

Shabason JE, Sutton D, Kenton O et al (2016) Patterns of failure for pediatric glioblastoma multiforme following radiation therapy. Pediatr Blood Cancer 63:1465–1467

PubMed  Article  Google Scholar 

Fangusaro J (2012) Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology. Front Oncol 2:105

PubMed  PubMed Central  Article  Google Scholar 

Cohen KJ, Pollack IF, Zhou T et al (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children’s Oncology Group. Neuro Oncol 13:317–323

CAS  PubMed  PubMed Central  Article  Google Scholar 

Janssens GO, Jansen MH, Lauwers SJ et al (2013) Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis. Int J Radiat Oncol Biol Phys 85:315–320

PubMed  Article  Google Scholar 

Janssens GO, Gandola L, Bolle S et al (2017) Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Eur J Cancer 73:38–47

PubMed  Article  Google Scholar 

Janjua MB, Ban VS, El Ahmadieh TY et al (2020) Diffuse intrinsic pontine gliomas: diagnostic approach and treatment strategies. J Clin Neurosci 72:15–19

CAS  PubMed  Article  Google Scholar 

Katagi H, Louis N, Unruh D et al (2019) Radiosensitization by Histone H3 demethylase inhibition in diffuse intrinsic pontine glioma. Clin Cancer Res 25:5572–5583

CAS  PubMed  PubMed Central  Article  Google Scholar 

Christensen M, Kamson DO, Snyder M et al (2014) Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients. J Radiat Oncol 3:131–138

CAS  PubMed  PubMed Central  Article  Google Scholar 

Law I, Albert NL, Arbizu J et al (2019) Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging 46:540–557

CAS  PubMed  Article  Google Scholar 

Huskisson E, Maggini S, Ruf M (2007) The role of vitamins and minerals in energy metabolism and well-being. J Int Med Res 35:277–289

CAS  PubMed  Article  Google Scholar 

Horn D, Barrientos A (2008) Mitochondrial copper metabolism and delivery to cytochrome c oxidase. IUBMB Life 60:421–429

CAS  PubMed  PubMed Central  Article  Google Scholar 

Brady DC, Crowe MS, Turski ML et al (2014) Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature 509:492–496

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ishida S, Andreux P, Poitry-Yamate C et al (2013) Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci U S A 110:19507–19512

CAS  PubMed  PubMed Central  Article  Google Scholar 

Shanbhag VC, Gudekar N, Jasmer K et al (2021) Copper metabolism as a unique vulnerability in cancer. Biochim Biophys Acta Mol Cell Res 1868:118893

CAS  PubMed  Article  Google Scholar 

Cui L, Gouw AM, LaGory EL et al (2021) Mitochondrial copper depletion suppresses triple-negative breast cancer in mice. Nat Biotechnol 39:357–367

CAS  PubMed  Article  Google Scholar 

Petruzzelli R, Polishchuk RS (2019) Activity and trafficking of copper-transporting ATPases in tumor development and defense against platinum-based drugs. Cells 8(9):1080

CAS  PubMed Central  Article  Google Scholar 

Williams HA, Robinson S, Julyan P et al (2005) A comparison of PET imaging characteristics of various copper radioisotopes. Eur J Nucl Med Mol Imaging 32:1473–1480

PubMed  Article  Google Scholar 

Bolzati C, Duatti A (2020) The emerging value of 64Cu for molecular imaging and therapy. Q J Nucl Med Mol Imaging 64:329–337

PubMed  Article  Google Scholar 

Bé MM, Cassette P, Lépy MC et al (2012) Standardization, decay data measurements and evaluation of 64Cu. Appl Radiat Isot 70:1894–1899

PubMed  Article  CAS  Google Scholar 

Righi S, Ugolini M, Bottoni G et al (2018) Biokinetic and dosimetric aspects of (64)CuCl(2) in human prostate cancer: possible theranostic implications. EJNMMI Res 8:18

PubMed  PubMed Central  Article  CAS  Google Scholar 

Panichelli P, Villano C, Cistaro A et al (2016) Imaging of brain tumors with copper-64 chloride: early experience and results. Cancer Biother Radiopharm 31:159–167

CAS  PubMed  Article  Google Scholar 

McCarthy DW, Shefer RE, Klinkowstein RE et al (1997) Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol 24:35–43

CAS  PubMed  Article  Google Scholar 

ICRP (1995) Basic anatomical & physiological data for use in radiological protection: the skeleton: the Skeleton. ICRP Publication 70. Ann ICRP 25:1–80

Siegel JA, Thomas SR, Stubbs JB et al (1999) MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 40:37s–61s

CAS  PubMed  Google Scholar 

Loeevinger R, Berman M (1968) A schema for absorbed-dose calculations for biologically-distributed radionuclides. J Nucl Med. Suppl 1:9–14

Snyder W, Ford, Warner GG, et al (1975) MIRD Pamphlet #11: S, absorbed dose per unit cumulated activity for selected radionuclides and organs

Stabin MG, Sparks RB, Crowe E (2005) OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 46:1023–1027

PubMed  Google Scholar 

ICRP (2007) The 2007 Recommendations of the International Commission on Radiological Protection (2007) ICRP publication 103. Ann ICRP 37:1–332

ICRP (1991) 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann ICRP 21:1–3

Cooney TM, Cohen KJ, Guimaraes CV et al (2020) Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 21:e330–e336

PubMed  Article  Google Scholar 

Pérès EA, Toutain J, Paty LP et al (2019) (64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study. EJNMMI Res 9:114

PubMed  PubMed Central  Article  CAS  Google Scholar 

Tateishi K, Tateishi U, Nakanowatari S et al (2014) (62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET. AJNR Am J Neuroradiol 35:278–284

CAS  PubMed  PubMed Central  Article  Google Scholar